Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder

American Journal of Pathology

Volumn 149, Issue 1, 1996, Pages 229-235

  Li, Maomi ^a   Zhang, Zuo Feng ^a   Reuter, Victor E ^a   Cordon Cardo, Carlos ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA;

ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER STAGING; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME DELETION; CHROMOSOME LOSS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

CARCINOMA, TRANSITIONAL CELL; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 3; COHORT STUDIES; DNA, NEOPLASM; DNA, SATELLITE; GENE DELETION; GENETIC MARKERS; HETEROZYGOTE; HUMANS; MICROSATELLITE REPEATS; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0029937281     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767
2. Levine AJ: The tumor suppressor genes. Annu Rev Biochem 1993, 62:623-51
3. Gibas Z, Prout GR, Connolly JG, Pontis JE, Sandberg AA: Non random chromosomal changes in transitional cell carcinoma of the bladder. Cancer Res 1984, 44: 1257-1264
4. Tsai YC, Nichols PW, Hiti AL, Williams Z, Skinner DG, Jones PA: Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer. Cancer Res 1990, 50:44-47
5. Presti Jr JC, Reuter V, Galan T, Fair WR, Cordon-Cardo C: Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res 1991, 51:5405-5409
6. Knowles MA, Elder PA, Williamson M, Cairns JP, Shaw ME, Law MG: Allelotype of human bladder cancer. Cancer Res 1994, 54:531-538
7. Habuchi T, Ogawa O, Kakehi Y, Ogura K, Koshiba M, Hamazaki S, Takahashi R, Sugiyama T, Yoshida O: Accumulated allelic losses in the development of invasive urothelial cancer. Int J Cancer 1993, 53:579-584
8. Orlow I, Lianes P, Lacombe L, Dalbagni G, Reuter VE, Cordon-Cardo C: Chromosome 9 allelic losses, and microsatellite alterations in human bladder tumors. Cancer Res 1994, 54:2848-2851
9. Johnson BE, Sakaguchi AY, Gazdar AF, Minna JD, Burch D, Angus M, Naylor SL: Restriction fragment length polymorphism studies show consistent loss of chromosome 3p alleles in small cell lung cancer patients' tumors. J Clin Invest 1988, 82:502-507
10. Presti JC, Reuter VE, Cordon-Cardo C, Mazumdar M, Fair WR, Jhanwar SC: Allelic deletions in renal tumors: histopathological correlations. Cancer Res 1993, 53: 5780-5783.
11. Anglard P, Troy K, Brauch H, Weiss GH, Latif F, Merino MJ, Lerman MI, Zbar B, Linehan WM: Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res 1991, 51:820-823
12. Maestro R, Gasparotto D, Vukosavljevic T, Barzen L, Sulfaro S, Boiocchi M: Three discrete regions of deletion at 3p in head and neck cancers. Cancer Res 1993, 53:5775-5779
13. Wu CL, Sloan P, Read AP, Harris R, Thakker N: Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity. Cancer Res 1994, 54:6484-6488
14. Yokoyama S, Yamakawa K, Tsuchiya E, Murata M, Sakiyama S, Nakamura Y: Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res 1992, 52:873-877
15. Chen L-C, Matsumura K, Deng G, Kurisu W, Ljung B-M, Lerman MI, Waldman FM, Smith HS: Deletion of two separate regions on chromosome 3p in breast cancers. Cancer Res 1994, 54:3021-3024
16. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J, Lindblom A, Tannergard P, Bollag RJ, Godwin AR, Ward DC, Nordenskjold M, Fishel R, Kolodner R, Liskay RM: Mutation in DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature (England) 1994, 368:258-261
17. Papadopoulos N, Nicolaides NC, Wei Y-F, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Hamilton SR, Petersen GM, Watson P, Lynch HT, Peltomaki P, Mecklin J-P, de la Chapelle A, Kinzler KW, Vogelstein B: Mutation of a MutL homolog in hereditary colon cancer. Science (Washington DC) 1994, 263:1625-1628
18. Latif F, Tory K, Gnarra J, Yao M, Duh F-M, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou F, Li H, Wei MH, Chen F, Glenn G, Choyke P, Walther MM, Weng Y, Duan D-SR Dean M, Glavac D, Richards FM, Crossey PA, Ferguson-Smith MA, Le Paslier D, Chumakov I, Cohen D, Chinault AC, Maher ER, Linehan WM, Zbar B, Lerman MI: Identification of von Hippel-Lindau disease tumor suppressor gene. Science (Washington DC) 1993, 260:1317-1322
19. McNeill Killary A, Wolf ME, Giambernadi TA, Naylor SL: Definition of a tumor suppressor locus within human chromosome 3p21-p22. Proc Natl Acad Sci USA 1992, 89:10877-10881
20. Dalbagni G, Presti J, Reuter V, Fair WR, Cordon-Cardo C: Genetic alterations in bladder cancer. The Lancet 1993, 342:469-471
21. Koi M, Umar A, Chauhan DP, Cherian SP, Carethers JM, Kunkel TA, Boland CR: Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res 1994, 54:4308-4312
22. Reuter VE, Melamed MR: The lower urinary tract. Diagnostic Surgical Pathology. Edited by SS Sternberg. New York, Raven Press, Ltd., 1994, pp 1767-1806
23. Mehta CR, Patel NR: A network algorithm for performing Fisher's Exact test in r × c contingency tables. J Am Stat Assoc 1983, 78:427-434
24. SAS Institute Inc. SAS/STAT User Guide. Version 6. Cary, NC: SAS Institute Inc., 1990,
25. Cairns P, Shaw ME, Knowles MA: Initiation of bladder cancer may involve deletion of a tumor-suppressor gene on chromosome 9. Oncogene 1993, 8:1083-1085
26. Sidransky D, Messing E: Molecular genetics and biochemical mechanisms in bladder cancer. Urologic Clinics of North America 1992, 19:629-639
27. Cordon-Cardo C, Dalbagni D, Sarkis A, Reuter VE: Genetic Alterations Associated With Bladder Cancer. Important Advances in Oncology, Edited by VT Devita, S Hellman, SA Rosenberg. J.B. Lippincott Company, Philadelphia, 1994,
28. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Melcklin J-P, Jarvinen H, Powell SM, Jen J, Hamilton SR, Peterson GM, Kinzler KW, Vogelstein B, de la Chapelle A: Clues to the pathogenesis of familial colorectal cancer. Science (Washington DC) 1993, 260:812-816
29. Thibodeau SN, Schaid GBD: Microsatellite instability in cancer of proximal colon. Science (Washington DC) 1993, 260:816-819
30. Meltzer S, Yin J, Manin B, Rhyu M-G, Cottrell J, Hudson E, Redd JL, Krasna MJ, Abraham JM, Reid B: Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrette's-associated esophageal adenocarcinomas. Cancer Res 1994, 54:3379-3382
31. Chong J-M, Fukayama M, Hayashi Y, Takizawa T, Koike M, Konishi M, Kikuchi-Yanoshita R, Miyaki M: Microsatellite instability in the progression of gastric carcinoma. Cancer Res 1994, 54:4595-4597
32. Merlo A, Mabry M, Gabrielson E, Vollmer R, Baylin, Sidransky D: Frequent microsatellite instability in primary small cell lung cancer. Cancer Res 1994, 54: 2098-2101
33. Risinger J, Berchuck A, Kohler MF, Watson P, Lynch HT, Boyd J: Genetic instability of microsatellites in endometrial carcinoma. Cancer Res 1993, 53:5100-5103
34. Gonzalez-Zulueta M, Ruppert JM, Tokino K, Tsai YC, Spruck III CH, Miyao N, Nichols PW, Hermann GG, Horn T, Kenneth S, Summerhayes IC, Sidransky D, Jones PA: Microsatellite instability in bladder cancer. Cancer Res 1993, 53:5620-5623
35. Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R The human mutator gene homolog MSH2, and its association with hereditary nonpolyposis colon cancer. Cell 1993, 75:1027-1038
36. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomaki P, Sistonen P, Aaltonen LA, Nystrom-Lahti M, Guan X-Y, Zhang J, Meltzer PS, Yu J-W, Kao F-T, Chen DJ, Cerosaletti KM, Fournier REK, Todd S, Lewis T, Leach RJ, Naylor SL, Weissenbach J, Mecklin, J-P, Jarvinea, H, Peterson GM, Hamilton SR, Green J, Jass J, Watson P, Lynch HT, Trent JM, de la Chapelle A, Kinzler KW, Vogelstein B: Mutations of a MUTs homolog in hereditary nonpolyposis colorectal cancer. Cell 1993, 75:1215-1225
37. Nicolaides NC, Papadopoulos N, Liu B, Wei Y-F, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Dunlop MG, Hamilton SR, Petersen GM, de la Chapelle A, Vogelstein B, Kinzler KW: Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature (England) 1994, 371:75-80
38. Matthew S, Nurty VVVS, Cheifetz S, George D, Massague, J, Chaganti RSK: Transforming growth factor receptor gene TGFβR2 maps to human chromosome band 3p22. Genomics 1994, 20:114-115
39. Massague J: Receptors for the TGF-β family. Cell 1992, 69:1067-1070
40. Kadin ME, Cavaille-Coll MW, Gertz R, Massague J, Cheifetz S, George D: Loss of receptors for transforming growth factor b in human T-cell malignancies. Proc Natl Acad Sci USA 1994, 91:6002-6006
41. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M, Willson JKV: Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC) 1995, 268:1336-1338
42. Gnarra JR, Troy K, Weng Y, Schmidt L, Wei M.H, Li H, Latif F, Liu S, Chen F, Duh F.-M, Lubensky I, Duan DR, Florence C, Pozzatti R, Walther MM, Bander NH, Grossman HB, Brauch H, Pomer S, Brooks JD, Isaacs WB, Lerman MI, Zbar B, Linehan WM: Mutations of the VHL tumor suppressor gene in renal carcinoma. Nat Genet 1994, 7:85-90